Health Canada has issued an interim policy notice effective September 14, 2026, outlining temporary measures to modernize clinical trial oversight in Canada. Intended to bridge the gap until the […]
On September 9, 2026, the U.S. Food and Drug Administration issued an update clarifying that it does not provide certificates, letters, emails, or any other official verification documents to […]
In case you missed our Member Alert last week, the anticipated Section 71 Notice has been published. The Member Alert can be found here.
Environment and Climate Change Canada (ECCC) sent a reminder to industries that Federal Plastics Registry (FPR) reports for the 2025 calendar year are due September 29, 2026. Reporting for Phases […]
The NNHPD is planning to revise the fish oil and other marine oil monographs in September 2026. Industry has requested greater flexibility regarding the declaration of omega-3 fatty acid content […]
This annual report is now available here. Highlights Signatories continued improving product-safety detection, monitoring and enforcement systems. Unsafe products were often removed proactively, before Program notification. 199 product listings were […]
Has been replaced by 2 new web pages. Overview of the Prescription Drug List Processes to amend the Prescription Drug List You can access the Prescription Drug List here.
The updated guidance will: Clarify the existing annual summary report requirements, including that reports should only be provided to the Minister upon receipt of a written request from Health […]
The revised guidance will: Clarify notification requirements and update the notification forms. Reduce duplicate and unnecessary reporting by clarifying when notifications are required. Reduce the reporting burden by cutting the […]
